Correlation Between Briacell Therapeutics and Grand Canyon

Can any of the company-specific risk be diversified away by investing in both Briacell Therapeutics and Grand Canyon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Briacell Therapeutics and Grand Canyon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Briacell Therapeutics Corp and Grand Canyon Education, you can compare the effects of market volatilities on Briacell Therapeutics and Grand Canyon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Briacell Therapeutics with a short position of Grand Canyon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Briacell Therapeutics and Grand Canyon.

Diversification Opportunities for Briacell Therapeutics and Grand Canyon

-0.58

Correlation Coefficient

Briacell Therapeutics  Grand Canyon

Excellent diversification

The 3 months correlation between Briacell and Grand is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Briacell Therapeutics Corp and Grand Canyon Education in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grand Canyon Education and Briacell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Briacell Therapeutics Corp are associated (or correlated) with Grand Canyon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grand Canyon Education has no effect on the direction of Briacell Therapeutics i.e., Briacell Therapeutics and Grand Canyon go up and down completely randomly.

Pair Corralation between Briacell Therapeutics and Grand Canyon

Given the investment horizon of 90 days Briacell Therapeutics Corp is expected to under-perform the Grand Canyon. In addition to that, Briacell Therapeutics is 2.67 times more volatile than Grand Canyon Education. It trades about -0.03 of its total potential returns per unit of risk. Grand Canyon Education is currently generating about 0.04 per unit of volatility. If you would invest  9,632  in Grand Canyon Education on January 20, 2024 and sell it today you would earn a total of  3,083  from holding Grand Canyon Education or generate 32.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Briacell Therapeutics Corp  vs.  Grand Canyon Education

Briacell Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Briacell Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Grand Canyon Education

Risk-Adjusted Performance

2 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Grand Canyon Education are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Grand Canyon is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Briacell Therapeutics and Grand Canyon

The main advantage of trading using opposite Briacell Therapeutics and Grand Canyon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Briacell Therapeutics position performs unexpectedly, Grand Canyon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grand Canyon will offset losses from the drop in Grand Canyon's long position.

The idea behind Briacell Therapeutics Corp and Grand Canyon Education pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..